As of June 17, 2025, PRA Health Sciences Inc (PRAH) reports a Gross Margin of 27.29%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of PRA Health Sciences Inc's Gross Margin
Over recent years, PRA Health Sciences Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2020-12-31 | 27.29% |
| 2019-12-31 | 28.59% |
| 2018-12-31 | 27.90% |
| 2017-12-31 | 29.41% |
| 2016-12-31 | 30.21% |
This gradual decrease highlights how PRA Health Sciences Inc manages its operational efficiency and pricing power over time.
Comparing PRA Health Sciences Inc's Gross Margin to Peers
To better understand PRA Health Sciences Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| PRA Health Sciences Inc (PRAH) | 27.29% |
| Abcellera Biologics Inc (ABCL) | 7775.20% |
| PerkinElmer Inc (PKI) | 6008.00% |
| Inotiv Inc (BASI) | 3015.93% |
| Replicel Life Sciences Inc (RP.V) | 100.00% |
| Quick-Med Technologies Inc (QMDT) | 97.31% |
Compared to its competitors, PRA Health Sciences Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.